Are you Dr. Atassi?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
41 Mall Rd
"# Lahey"
Boston, MA 01805Phone+1 617-643-0842
Summary
- Dr. Nazem Atassi, MD is a board certified neurologist in Boston, Massachusetts. He is currently licensed to practice medicine in Massachusetts. He is an Assistant Professor of Neurology at Massachusetts General Hospital.
Education & Training
- Damascus University Faculty of MedicineClass of 2002
Certifications & Licensure
- MA State Medical License 2008 - 2027
- American Board of Psychiatry and Neurology Neurology
Publications & Presentations
PubMed
- 7 citationsSafety, pharmacokinetics, and target engagement of a brain penetrant RIPK1 inhibitor, SAR443820 (DNL788), in healthy adult participants.Agnes Hincelin-Mery, Xavier Nicolas, Cathy Cantalloube, Robert Pomponio, Pascale Lewanczyk
Clinical and Translational Science. 2024-01-01 - 6 citationsAn innovative phase 2 proof-of-concept trial design to evaluate SAR445088, a monoclonal antibody targeting complement C1s in chronic inflammatory demyelinating polyneu...Luis Querol, Richard A Lewis, Hans-Peter Hartung, Pieter A Van Doorn, Erik Wallstroem
Journal of the Peripheral Nervous System. 2023-06-01 - 28 citationsClassical Complement Pathway Inhibition in a "Human-On-A-Chip" Model of Autoimmune Demyelinating Neuropathies.John W Rumsey, Case Lorance, Max Jackson, Trevor Sasserath, Christopher W McAleer
Advanced Therapeutics. 2022-06-01
Press Mentions
- MediciNova Announces Full Enrollment in ALS Biomarker Clinical TrialJuly 29th, 2018
- New Imaging Protocol Could Vastly Accelerate Clinical Trials for New ALS TreatmentsMay 31st, 2018
- Mass General Investigators on the Cutting Edge of ALS ResearchMay 10th, 2018
- Join now to see all